Ohuchi, K., Kambayashi, Y., Hidaka, T., & Fujimura, T. (2021). Plasminogen Activating Inhibitor-1 Might Predict the Efficacy of Anti-PD1 Antibody in Advanced Melanoma Patients. Frontiers Media S.A.
Chicago Style (17th ed.) CitationOhuchi, Kentaro, Yumi Kambayashi, Takanori Hidaka, and Taku Fujimura. Plasminogen Activating Inhibitor-1 Might Predict the Efficacy of Anti-PD1 Antibody in Advanced Melanoma Patients. Frontiers Media S.A, 2021.
MLA (8th ed.) CitationOhuchi, Kentaro, et al. Plasminogen Activating Inhibitor-1 Might Predict the Efficacy of Anti-PD1 Antibody in Advanced Melanoma Patients. Frontiers Media S.A, 2021.
Warning: These citations may not always be 100% accurate.